Variant report
Variant | esv2758445 |
---|---|
Chromosome Location | chr17:20287295-20699840 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1965)
- CpG islands (count:3176)
- Chromatin interactive region (count:13)
- LncRNA region (count:48)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr17:20637414-20637538 | K562 | blood: | n/a | n/a |
2 | ATF2 | chr17:20552401-20552830 | GM12878 | blood: | n/a | n/a |
3 | ATF2 | chr17:20552417-20552929 | GM12878 | blood: | n/a | n/a |
4 | BACH1 | chr17:20388438-20388633 | H1-hESC | embryonic stem cell: | n/a | n/a |
5 | BATF | chr17:20573899-20574074 | GM12878 | blood: | n/a | n/a |
6 | BATF | chr17:20354311-20354673 | GM12878 | blood: | n/a | chr17:20354476-20354487 |
7 | BATF | chr17:20552419-20552811 | GM12878 | blood: | n/a | n/a |
8 | BATF | chr17:20554357-20554645 | GM12878 | blood: | n/a | n/a |
9 | BATF | chr17:20339605-20339854 | GM12878 | blood: | n/a | chr17:20339773-20339784 chr17:20339774-20339784 |
10 | BATF | chr17:20443708-20444186 | GM12878 | blood: | n/a | n/a |
11 | BATF | chr17:20602187-20602524 | GM12878 | blood: | n/a | n/a |
12 | BATF | chr17:20602164-20602479 | GM12878 | blood: | n/a | n/a |
13 | BATF | chr17:20568713-20568948 | GM12878 | blood: | n/a | chr17:20568784-20568795 |
14 | BATF | chr17:20552423-20552925 | GM12878 | blood: | n/a | n/a |
15 | BATF | chr17:20370787-20371117 | GM12878 | blood: | n/a | n/a |
16 | BATF | chr17:20339552-20339955 | GM12878 | blood: | n/a | chr17:20339773-20339784 chr17:20339774-20339784 |
17 | BATF | chr17:20354345-20354597 | GM12878 | blood: | n/a | chr17:20354476-20354487 |
18 | BATF | chr17:20443556-20444223 | GM12878 | blood: | n/a | n/a |
19 | BATF | chr17:20370764-20371076 | GM12878 | blood: | n/a | n/a |
20 | BATF | chr17:20449270-20449503 | GM12878 | blood: | n/a | n/a |
21 | BCL11A | chr17:20443777-20444111 | GM12878 | blood: | n/a | n/a |
22 | BCL11A | chr17:20370709-20371057 | GM12878 | blood: | n/a | n/a |
23 | BCL11A | chr17:20552438-20552751 | GM12878 | blood: | n/a | n/a |
24 | BCL11A | chr17:20326172-20326448 | GM12878 | blood: | n/a | n/a |
25 | BCL11A | chr17:20443676-20444145 | GM12878 | blood: | n/a | n/a |
26 | BCL11A | chr17:20371063-20371231 | GM12878 | blood: | n/a | n/a |
27 | BCL11A | chr17:20581794-20582050 | GM12878 | blood: | n/a | chr17:20582005-20582012 |
28 | BCL11A | chr17:20602069-20602629 | GM12878 | blood: | n/a | n/a |
29 | BCL11A | chr17:20370806-20371041 | GM12878 | blood: | n/a | n/a |
30 | BCL11A | chr17:20372530-20372862 | GM12878 | blood: | n/a | n/a |
31 | BCL11A | chr17:20554373-20554609 | GM12878 | blood: | n/a | n/a |
32 | BCL11A | chr17:20559489-20559685 | GM12878 | blood: | n/a | n/a |
33 | BCL11A | chr17:20603932-20604264 | GM12878 | blood: | n/a | n/a |
34 | BCL11A | chr17:20602137-20602533 | GM12878 | blood: | n/a | n/a |
35 | BCL11A | chr17:20552374-20552875 | GM12878 | blood: | n/a | n/a |
36 | BCL11A | chr17:20554375-20554592 | GM12878 | blood: | n/a | n/a |
37 | BCL3 | chr17:20674383-20674846 | GM12878 | blood: | n/a | n/a |
38 | BCL3 | chr17:20438566-20438789 | GM12878 | blood: | n/a | n/a |
39 | BCL3 | chr17:20674472-20674782 | GM12878 | blood: | n/a | n/a |
40 | BHLHE40 | chr17:20354420-20354612 | K562 | blood: | n/a | n/a |
41 | BHLHE40 | chr17:20514794-20515059 | K562 | blood: | n/a | chr17:20514926-20514939 chr17:20514929-20514938 chr17:20514928-20514937 |
42 | BHLHE40 | chr17:20552469-20552691 | GM12878 | blood: | n/a | n/a |
43 | BHLHE40 | chr17:20602321-20602362 | GM12878 | blood: | n/a | n/a |
44 | CEBPB | chr17:20694201-20694462 | A549 | lung: | n/a | n/a |
45 | CEBPB | chr17:20694124-20694444 | HepG2 | liver: | n/a | n/a |
46 | CEBPB | chr17:20624556-20624832 | A549 | lung: | n/a | n/a |
47 | CEBPB | chr17:20568666-20568987 | K562 | blood: | n/a | chr17:20568791-20568804 |
48 | CEBPB | chr17:20621783-20621875 | A549 | lung: | n/a | n/a |
49 | CEBPB | chr17:20516625-20516934 | HepG2 | liver: | n/a | n/a |
50 | CEBPB | chr17:20625585-20625841 | HepG2 | liver: | n/a | chr17:20625724-20625737 |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:20346491-20346541 | HepG2 | liver: | n/a |
2 | chr17:20536885-20536935 | SKMC | muscle: | n/a |
3 | chr17:20450466-20450516 | HEEpiC | esophagus: | n/a |
4 | chr17:20446526-20446576 | HRPEpiC | eye: | n/a |
5 | chr17:20346491-20346541 | HepG2 | liver: | n/a |
6 | chr17:20536885-20536935 | SKMC | muscle: | n/a |
7 | chr17:20450466-20450516 | HEEpiC | esophagus: | n/a |
8 | chr17:20446526-20446576 | HRPEpiC | eye: | n/a |
9 | chr17:20450484-20450534 | GM12891 | blood: | n/a |
10 | chr17:20464366-20464416 | AG04449 | skin: | fetal |
11 | chr17:20408647-20408697 | GM06990 | blood: | n/a |
12 | chr17:20688522-20688572 | GM12892 | blood: | n/a |
13 | chr17:20688483-20688533 | K562 | blood: | n/a |
14 | chr17:20688483-20688533 | Caco-2 | colon: | n/a |
15 | chr17:20492631-20492681 | SKMC | muscle: | n/a |
16 | chr17:20448558-20448608 | Jurkat | blood: | n/a |
17 | chr17:20464366-20464416 | AG09319 | gingival: | n/a |
18 | chr17:20409125-20409175 | NHDF-neo | bronchial: | n/a |
19 | chr17:20408647-20408697 | NHBE | bronchial: | n/a |
20 | chr17:20688483-20688533 | Hela-S3 | cervix: | n/a |
21 | chr17:20492631-20492681 | AG09319 | gingival: | n/a |
22 | chr17:20408647-20408697 | HMEC | breast: | n/a |
23 | chr17:20409125-20409175 | NB4 | blood: | n/a |
24 | chr17:20536885-20536935 | HCPEpiC | choroid plexus: | n/a |
25 | chr17:20370597-20370647 | MCF10A-Er-Src | breast: | n/a |
26 | chr17:20516820-20516870 | Hela-S3 | cervix: | n/a |
27 | chr17:20465437-20465487 | SK-N-SH | brain: | n/a |
28 | chr17:20339878-20339928 | AoSMC | blood vessel: | n/a |
29 | chr17:20454132-20454182 | LNCaP | prostate: | n/a |
30 | chr17:20493503-20493553 | ProgFib | skin: | n/a |
31 | chr17:20467831-20467881 | HCPEpiC | choroid plexus: | n/a |
32 | chr17:20454132-20454182 | SAEC | small airway: | n/a |
33 | chr17:20433187-20433237 | HIPEpiC | eye: | n/a |
34 | chr17:20460588-20460638 | NB4 | blood: | n/a |
35 | chr17:20492631-20492681 | NT2-D1 | testis: | n/a |
36 | chr17:20465437-20465487 | RPTEC | kidney: | n/a |
37 | chr17:20465437-20465487 | Caco-2 | colon: | n/a |
38 | chr17:20687681-20687731 | AoSMC | blood vessel: | n/a |
39 | chr17:20683924-20683974 | MCF-7 | breast: | n/a |
40 | chr17:20687912-20687962 | CMK | blood: | n/a |
41 | chr17:20454132-20454182 | SKMC | muscle: | n/a |
42 | chr17:20409125-20409175 | ECC-1 | luminal epithelium: | n/a |
43 | chr17:20683924-20683974 | HRPEpiC | eye: | n/a |
44 | chr17:20491042-20491092 | HepG2 | liver: | n/a |
45 | chr17:20536885-20536935 | BJ | skin: | n/a |
46 | chr17:20489071-20489121 | GM19239 | blood: | n/a |
47 | chr17:20405382-20405432 | HL-60 | blood: | n/a |
48 | chr17:20408772-20408822 | HepG2 | liver: | n/a |
49 | chr17:20491042-20491092 | GM12892 | blood: | n/a |
50 | chr17:20516820-20516870 | HIPEpiC | eye: | n/a |
(count:13 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:18289123..18291183-chr17:20462480..20465308,2 | MCF-7 | breast: | |
2 | chr17:20649661..20650164-chr17:58032683..58033398,2 | MCF-7 | breast: | |
3 | chr17:20651225..20652727-chr17:58034005..58036459,2 | MCF-7 | breast: | |
4 | chr17:20647874..20648866-chr17:58031160..58032144,3 | MCF-7 | breast: | |
5 | chr17:20639441..20641960-chr17:20642430..20644326,2 | K562 | blood: | |
6 | chr17:20689022..20691056-chr17:20693730..20696703,2 | K562 | blood: | |
7 | chr17:20639441..20641960-chr17:20642430..20644326,2 | K562 | blood: | |
8 | chr17:20610050..20610947-chr17:30454022..30454629,2 | Hela-S3 | cervix: | |
9 | chr17:20698627..20701345-chr17:20703321..20705574,3 | K562 | blood: | |
10 | chr17:20640004..20640962-chr17:58024195..58025007,2 | MCF-7 | breast: | |
11 | chr17:20646890..20651186-chr17:58030459..58033432,3 | MCF-7 | breast: | |
12 | chr17:20649688..20651234-chr17:58034050..58037704,4 | MCF-7 | breast: | |
13 | chr17:20689022..20691056-chr17:20693730..20696703,2 | K562 | blood: |
(count:48 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-LGALS9B-13 | chr17:20458740-20458896 | NONHSAT146793 |
2 | lnc-LGALS9B-12 | chr17:20446789-20446842 | NONHSAT146601 |
3 | lnc-FAM106B-2 | chr17:20337350-20337598 | ENSG00000265556.1 |
4 | lnc-CCDC144C-1 | chr17:20303834-20303876 | NR_023380 |
5 | lnc-CDRT15L2-1 | chr17:20691384-20692912 | NONHSAT146833 |
6 | lnc-CCDC144NL-9 | chr17:20354914-20355028 | NONHSAT146573 |
7 | lnc-CCDC144NL-9 | chr17:20355664-20355708 | NONHSAT146574 |
8 | lnc-CCDC144NL-9 | chr17:20355108-20355484 | NONHSAT146573 |
9 | lnc-LGALS9B-3 | chr17:20517801-20517981 | ENSG00000227685.1 |
10 | lnc-FAM106B-1 | chr17:20320763-20321272 | NONHSAT146571 |
11 | lnc-LGALS9B-2 | chr17:20479798-20480107 | XLOC_012419 |
12 | lnc-LGALS9B-2 | chr17:20481940-20482061 | ENSG00000264422.1 |
13 | lnc-LGALS9B-2 | chr17:20481940-20482149 | XLOC_012419 |
14 | lnc-FAM106B-2 | chr17:20336519-20336570 | ENSG00000265556.1 |
15 | lnc-LGALS9B-2 | chr17:20478895-20479172 | XLOC_012419 |
16 | lnc-LGALS9B-12 | chr17:20447359-20447436 | NONHSAT146601 |
17 | lnc-LGALS9B-13 | chr17:20462661-20462723 | NONHSAT146793 |
18 | lnc-LGALS9B-2 | chr17:20478895-20479010 | XLOC_012419 |
19 | lnc-LGALS9B-7 | chr17:20410726-20412244 | ENSG00000266925.1 |
20 | lnc-LGALS9B-4 | chr17:20375554-20376706 | ucscGeneNc_uc002gxd_1 |
21 | lnc-LGALS9B-3 | chr17:20536350-20536547 | ENSG00000227685.1 |
22 | lnc-CCDC144NL-9 | chr17:20356330-20356786 | NONHSAT146574 |
23 | lnc-LGALS9B-2 | chr17:20479798-20480255 | XLOC_012419 |
24 | lnc-CDRT15L2-1 | chr17:20692057-20692707 | XLOC_012138 |
25 | lnc-CCDC144NL-4 | chr17:20692530-20692908 | NONHSAT146835 |
26 | lnc-CCDC144NL-5 | chr17:20674371-20674740 | NONHSAT146831 |
27 | lnc-LGALS9B-3 | chr17:20534785-20534862 | ENSG00000227685.1 |
28 | lnc-LGALS9B-2 | chr17:20478827-20479172 | XLOC_012419 |
29 | lnc-LGALS9B-4 | chr17:20373955-20374185 | ucscGeneNc_uc002gxd_1 |
30 | lnc-CCDC144C-1 | chr17:20294788-20295081 | NR_023380 |
31 | lnc-CCDC144NL-9 | chr17:20355135-20355196 | NONHSAT146574 |
32 | lnc-LGALS9B-13 | chr17:20459470-20459532 | NONHSAT146793 |
33 | lnc-LGALS9B-2 | chr17:20479980-20480210 | ENSG00000264422.1 |
34 | lnc-LGALS9B-2 | chr17:20479866-20480107 | XLOC_012419 |
35 | lnc-LGALS9B-3 | chr17:20536347-20536572 | NONHSAT146828 |
36 | lnc-CCDC144C-1 | chr17:20295677-20295897 | NR_023380 |
37 | lnc-CDRT15L2-1 | chr17:20691697-20691952 | XLOC_012138 |
38 | lnc-LGALS9B-2 | chr17:20479798-20480107 | XLOC_012419 |
39 | lnc-LGALS9B-1 | chr17:20433355-20434194 | ENSG00000260907.1 |
40 | lnc-FAM106B-1 | chr17:20320741-20322363 | NONHSAT146570 |
41 | lnc-LGALS9B-12 | chr17:20446287-20446510 | NONHSAT146601 |
42 | lnc-CDRT15L2-1 | chr17:20691384-20692897 | ENSG00000264215.1 |
43 | lnc-CCDC144C-1 | chr17:20305369-20305504 | NR_023380 |
44 | lnc-LGALS9B-2 | chr17:20481940-20482234 | XLOC_012419 |
45 | lnc-LGALS9B-2 | chr17:20481940-20482234 | XLOC_012419 |
46 | lnc-LGALS9B-3 | chr17:20516225-20516387 | ENSG00000227685.1 |
47 | lnc-CDRT15L2-5 | chr17:20678955-20680218 | NONHSAT146832 |
48 | lnc-LGALS9B-10 | chr17:20435561-20436194 | NONHSAT146584 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000227685 | TF binding region |
FAM106B | TF binding region |
ENSG00000263946 | TF binding region |
ENSG00000230339 | TF binding region |
ENSG00000264874 | TF binding region |
ENSG00000265916 | TF binding region |
ENSG00000205215 | TF binding region |
COTL1P2 | TF binding region |
USP32P3 | TF binding region |
HNRNPA1P19 | TF binding region |
ENSG00000264422 | TF binding region |
ZSWIM5P2 | TF binding region |
SRP68P3 | TF binding region |
ENSG00000232889 | TF binding region |
ENSG00000229586 | TF binding region |
ENSG00000235546 | TF binding region |
ENSG00000264662 | TF binding region |
ENSG00000266364 | TF binding region |
ENSG00000265556 | TF binding region |
LGALS9B | TF binding region |
CDRT15L2 | TF binding region |
OLA1P2 | TF binding region |
ENSG00000260907 | TF binding region |
YWHAEP3 | TF binding region |
ENSG00000266042 | TF binding region |
NOS2P3 | TF binding region |
KRT16P5 | TF binding region |
ENSG00000266925 | TF binding region |
SCDP1 | TF binding region |
ENSG00000231645 | TF binding region |
MEIS3P2 | TF binding region |
ENSG00000236504 | TF binding region |
ENSG00000226521 | TF binding region |
ENSG00000264215 | TF binding region |
ENSG00000226096 | TF binding region |
TBC1D3P3 | TF binding region |
RNFT1P3 | TF binding region |
KRT16P3 | TF binding region |
ENSG00000264981 | TF binding region |
ENSG00000267075 | TF binding region |
ENSG00000227685 | CpG island |
FAM106B | CpG island |
ENSG00000263946 | CpG island |
ENSG00000230339 | CpG island |
ENSG00000264874 | CpG island |
ENSG00000265916 | CpG island |
ENSG00000205215 | CpG island |
COTL1P2 | CpG island |
USP32P3 | CpG island |
HNRNPA1P19 | CpG island |
ENSG00000264422 | CpG island |
ZSWIM5P2 | CpG island |
SRP68P3 | CpG island |
ENSG00000232889 | CpG island |
ENSG00000229586 | CpG island |
ENSG00000235546 | CpG island |
ENSG00000264662 | CpG island |
ENSG00000266364 | CpG island |
ENSG00000265556 | CpG island |
LGALS9B | CpG island |
CDRT15L2 | CpG island |
OLA1P2 | CpG island |
ENSG00000260907 | CpG island |
YWHAEP3 | CpG island |
ENSG00000266042 | CpG island |
NOS2P3 | CpG island |
KRT16P5 | CpG island |
ENSG00000266925 | CpG island |
SCDP1 | CpG island |
ENSG00000231645 | CpG island |
MEIS3P2 | CpG island |
ENSG00000236504 | CpG island |
ENSG00000226521 | CpG island |
ENSG00000264215 | CpG island |
ENSG00000226096 | CpG island |
TBC1D3P3 | CpG island |
RNFT1P3 | CpG island |
KRT16P3 | CpG island |
ENSG00000264981 | CpG island |
ENSG00000267075 | CpG island |
ENSG00000214860 | chromatin interactions |
ENSG00000189050 | chromatin interactions |
ENSG00000108443 | chromatin interactions |
GTF3C4 | miRNA target sites |
RNF125 | miRNA target sites |
VPS4B | miRNA target sites |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542720929 | chr17:20291227-20291228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs560999716 | chr17:20291237-20291238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs528260218 | chr17:20291240-20291241 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs2694238 | chr17:20291251-20291252 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs9912844 | chr17:20291257-20291258 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs2694237 | chr17:20291305-20291306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs367745822 | chr17:20291308-20291309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138582554 | chr17:20291314-20291315 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs149326283 | chr17:20291325-20291326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs3874835 | chr17:20291387-20291388 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs550891008 | chr17:20291438-20291439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs569156844 | chr17:20291450-20291451 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs530067183 | chr17:20291478-20291479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs548263834 | chr17:20291501-20291502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs186405761 | chr17:20291524-20291525 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs148408577 | chr17:20291550-20291551 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564773812 | chr17:20291563-20291564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566642296 | chr17:20291598-20291599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs144988873 | chr17:20291628-20291629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs565224760 | chr17:20291657-20291658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs571086025 | chr17:20291667-20291668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112291584 | chr17:20291695-20291696 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs538148091 | chr17:20291722-20291723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2694234 | chr17:20291735-20291736 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs575113801 | chr17:20291767-20291768 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs9897871 | chr17:20291779-20291780 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
27 | rs554676271 | chr17:20291852-20291853 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs572975875 | chr17:20291873-20291874 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs540385987 | chr17:20291889-20291890 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564920709 | chr17:20291960-20291961 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs577012495 | chr17:20292063-20292064 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs544159268 | chr17:20292072-20292073 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562838407 | chr17:20292128-20292129 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530005847 | chr17:20292133-20292134 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548200589 | chr17:20292140-20292141 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560166485 | chr17:20292161-20292162 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs527791260 | chr17:20292238-20292239 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs552681142 | chr17:20292247-20292248 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs570933711 | chr17:20292278-20292279 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs144297563 | chr17:20292314-20292315 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
41 | rs182075870 | chr17:20292356-20292357 | Active TSS | n/a | n/a | Overlapped CNVs | n/a |
42 | rs16941857 | chr17:20292395-20292396 | Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs536205373 | chr17:20292448-20292449 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
44 | rs554612096 | chr17:20292485-20292486 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572915577 | chr17:20292487-20292488 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
46 | rs566454468 | chr17:20292505-20292506 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558649587 | chr17:20292576-20292577 | Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
48 | rs202156910 | chr17:20294824-20294825 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs545837489 | chr17:20294974-20294975 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs558120699 | chr17:20294978-20294979 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Chordoma | 21602918 | CNVD |
Miller-Dieker syndrome | 22283845 | CNVD |
Non-syndromic sensorineural hearing loss | 17457615 | CNVD |
Cancer | 22429812 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 20837533 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
colon cancer | 17210682 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Chronic lymphocytic leukemia | 17971485 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 16461572 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 17133270 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Moyamoya disease | 22323933 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20724749 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Colorectal cancer | 21645411 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
HIV/AIDS | 17953491 | CNVD |
HIV/AIDS | 20877625 | CNVD |
Immune disease | 21076436 | CNVD |
Rheumatoid arthritis | 17953491 | CNVD |
Type 1 diabetes | 17953491 | CNVD |
HIV/AIDS | 15637236 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Neurofibromatosis | 18196300 | CNVD |
Breast cancer | 17001317 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Charcot-marie-tooth disease | 16463004 | CNVD |
Osteosarcoma | 22292074 | CNVD |
Breast cancer | 17603634 | CNVD |
Charcot | 16760730 | CNVD |
Mental retardation | 17901693 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Smith-Magenis syndrome | 18923513 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16272173 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22492990 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 18414209 | CNVD |
Developmental delay | 21549014 | CNVD |
Epilepsy | 20970697 | CNVD |
Mental retardation | 18414209 | CNVD |
Mental retardation | 21549014 | CNVD |
Smith-Magenis syndrome | 21981782 | CNVD |
Smith-Magenis syndrome | 20188345 | CNVD |
Smith-Magenis syndrome | 16775514 | CNVD |
Smith-Magenis syndrome | 22585170 | CNVD |
Smith-Magenis syndrome | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Mental retardation | 19951919 | CNVD |
Potocki-Lupski syndrome | 21271655 | CNVD |
Potocki-lupski syndrome | 17357070 | CNVD |
Potocki-lupski syndrome | 20110824 | CNVD |
Potocki-lupski syndrome | 18923514 | CNVD |
Potocki-lupski syndrome | 22241247 | CNVD |
Potocki-lupski syndrome | 20188345 | CNVD |
Schizophrenia | 21399695 | CNVD |
Mental retardation | 16773131 | CNVD |
Adenocarcinoma | 19607727 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Charcot-marie-tooth disease | 22470819 | CNVD |
Neurofibromatosis | 22470819 | CNVD |
Neuropathy | 22470819 | CNVD |
Smith-Magenis syndrome | 18301319 | CNVD |
Smith-Magenis syndrome | 17357070 | CNVD |
Smith-Magenis syndrome | 18469339 | CNVD |
Smith-Magenis syndrome | 22241097 | CNVD |
Smith-Magenis syndrome | 22470819 | CNVD |
Tourette syndrome | 18923514 | CNVD |
Type 1 diabetes | 22470819 | CNVD |
Potocki-lupski syndrome | 18469339 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Neuropathy | 17597781 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 17015230 | CNVD |
Smith-Magenis syndrome | 17597781 | CNVD |
Potocki-lupski syndrome | 18059269 | CNVD |
Potocki-lupski syndrome | 17597781 | CNVD |
Mental retardation | 17847001 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Breast cancer | 20409316 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 17440070 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 17142309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:20291200-20291800 | Enhancers | Thymus | Thymus |
2 | chr17:20291800-20292000 | Flanking Active TSS | Thymus | Thymus |
3 | chr17:20292000-20292400 | Active TSS | Thymus | Thymus |
4 | chr17:20292400-20292600 | Flanking Active TSS | Thymus | Thymus |
5 | chr17:20304000-20304800 | Enhancers | NHEK | skin |
6 | chr17:20304800-20305600 | Weak transcription | NHEK | skin |
7 | chr17:20305600-20305800 | Enhancers | NHEK | skin |
8 | chr17:20314600-20337600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
9 | chr17:20325200-20325600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
10 | chr17:20325200-20325800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
11 | chr17:20325200-20326000 | Enhancers | Primary monocytes fromperipheralblood | blood |
12 | chr17:20325200-20326000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
13 | chr17:20325200-20326000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
14 | chr17:20325600-20326000 | Flanking Active TSS | Monocytes-CD14+_RO01746 | blood |
15 | chr17:20326400-20327200 | Enhancers | Primary B cells from peripheral blood | blood |
16 | chr17:20326800-20336400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
17 | chr17:20327400-20334600 | Weak transcription | Brain Angular Gyrus | brain |
18 | chr17:20327600-20327800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
19 | chr17:20330600-20336800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
20 | chr17:20348000-20348200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
21 | chr17:20350200-20350800 | Enhancers | HUES6 Cell Line | embryonic stem cell |
22 | chr17:20354000-20354200 | Active TSS | Hela-S3 | cervix |
23 | chr17:20354000-20355400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
24 | chr17:20354200-20354400 | Flanking Active TSS | Hela-S3 | cervix |
25 | chr17:20354200-20355200 | Enhancers | Primary T cells fromperipheralblood | blood |
26 | chr17:20354400-20355200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
27 | chr17:20354800-20355200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
28 | chr17:20357200-20369000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
29 | chr17:20358200-20368800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
30 | chr17:20366000-20366200 | Enhancers | Rectal Mucosa Donor 29 | rectum |
31 | chr17:20366200-20369200 | Weak transcription | Rectal Mucosa Donor 29 | rectum |
32 | chr17:20368200-20368400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
33 | chr17:20368400-20369000 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
34 | chr17:20368800-20369800 | Strong transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
35 | chr17:20369000-20369400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
36 | chr17:20369000-20369600 | Strong transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
37 | chr17:20369000-20370800 | Enhancers | Rectal Mucosa Donor 31 | rectum |
38 | chr17:20369200-20370800 | Active TSS | Rectal Mucosa Donor 29 | rectum |
39 | chr17:20369400-20369600 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
40 | chr17:20369400-20369800 | Flanking Active TSS | Primary Natural Killer cells fromperipheralblood | blood |
41 | chr17:20369400-20369800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
42 | chr17:20369400-20370800 | Enhancers | Primary T cells fromperipheralblood | blood |
43 | chr17:20369600-20370400 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
44 | chr17:20369600-20370400 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
45 | chr17:20369600-20370600 | Enhancers | Esophagus | oesophagus |
46 | chr17:20369800-20370200 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
47 | chr17:20369800-20370400 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
48 | chr17:20369800-20380000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
49 | chr17:20370200-20370400 | Enhancers | GM12878-XiMat | blood |
50 | chr17:20370200-20370800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |